2020
DOI: 10.1248/cpb.c19-00927
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening

Abstract: Discovery of novel multifunctional inhibitors targeting acetylcholinesterase (AChE) has becoming a hot spot in anti-Alzheimer's disease (AD) drug development. In the present study, four potent small molecule inhibitors (A01, A02, A03 and A04) of AChE with new chemical scaffold were identified. Inhibitor A03 displayed the most potent inhibition activity on AChE at enzymatic level with IC 50 value of 180 nM, and high selectivity towards AChE over butyrylcholinesterase (BChE) by more than 100-fold. The binding mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 33 publications
(33 reference statements)
0
3
0
Order By: Relevance
“…Kumarasiri M et al reported by virtual screening that seven drug-like molecules, identified as potential cyclin-dependent kinase (CDK) 8 inhibitors, were active against colorectal cancer cell lines [26]. Another virtual screening model was established to successfully find acetylcholinesterase (AChE) inhibitors with the ability of protecting human neuroblastoma cells from Aβ-induced injury for Alzheimer's disease treatment [27]. Furthermore, in the onset of the COVID-19 pandemic, there was a strong interest in rapidly and economically finding effective anti-coronavirus agents.…”
Section: Discussionmentioning
confidence: 99%
“…Kumarasiri M et al reported by virtual screening that seven drug-like molecules, identified as potential cyclin-dependent kinase (CDK) 8 inhibitors, were active against colorectal cancer cell lines [26]. Another virtual screening model was established to successfully find acetylcholinesterase (AChE) inhibitors with the ability of protecting human neuroblastoma cells from Aβ-induced injury for Alzheimer's disease treatment [27]. Furthermore, in the onset of the COVID-19 pandemic, there was a strong interest in rapidly and economically finding effective anti-coronavirus agents.…”
Section: Discussionmentioning
confidence: 99%
“…Butyrylcholinesterase (BuChE) has also had a great effect on the advancement of AD. BuChE inhibitors could retrieve cholinergic activity via restoring the proportions of AChE/BuChE activity like in a normal brain ( Liu et al, 2020 ). As a consequence, dual AChE/BuChE inhibitors have drawn great interest in the management of AD ( Davidsson et al, 2001 ).…”
Section: Introductionmentioning
confidence: 99%
“…These biochemical reactions are very vital to allow a cholinergic neuron to return to its normal resting state after activation [ 11 ]. For example, acetylcholine at a motor enclave triggers muscle contraction, for the muscle to relax afterward cholinesterase has to act to neutralize acetylcholine rather than remaining locked in a tense state [ 12 ].…”
Section: Introductionmentioning
confidence: 99%